BRAFV600E, the most frequent mutation in cutaneous melanomas, downregulates the expression of MITF and its downstream effectors operating in the differentiation pathway, while MITF expression is increased by BRAF inhibitors [65, 66]. The gene discussed is MITF; the disease is cutaneous melanoma.